Business ❯ Investing ❯ Pharmaceuticals

Manufacturing

Eli Lilly Job Creation AstraZeneca Active Pharmaceutical Ingredients Johnson & Johnson Vaccine Development U.S. Manufacturing Pharmaceutical Facilities Cell Therapy Roche Novo Nordisk Roche Holdings AG Facility Development Supply Chain Eli Lilly and Company

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

The upgrade positions the site to supply markets outside the U.S. ahead of a possible EMA decision on the Wegovy pill.

AbbVie to Invest $380 Million in Two North Chicago API Plants

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

Merck Breaks Ground on $3 Billion Virginia Plant in $70 Billion U.S. Expansion

AstraZeneca Breaks Ground on $4.5 Billion Virginia Plant With Expanded Cancer and Obesity Drug Production

Eli Lilly Chooses Houston for $6.5 Billion Plant to Produce APIs for Orforglipron and Other Drugs

J&J Commits $2 Billion to 10-Year Fujifilm Deal for North Carolina Biologics Hub

AbbVie to Build $195 Million API Facility in North Chicago

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030